Molecules at Play in Cancer
| dc.contributor.editor | Iacobas, Dumitru | |
| dc.date.accessioned | 2023-05-11T17:21:29Z | |
| dc.date.available | 2023-05-11T17:21:29Z | |
| dc.date.issued | 2023 | |
| dc.identifier | ONIX_20230511_9783036573038_131 | |
| dc.identifier.uri | https://directory.doabooks.org/handle/20.500.12854/100114 | |
| dc.description.abstract | "Molecules at Play in Cancer" is a collection of 24 research articles on recent findings about some important molecules responsible for either cancer development and proliferation, or anti-cancer therapy. It covers a wide range of tissues and organs affected by cancer: adrenal glands, blood, breasts, muscles, ovaries, prostate, stomach, and testicles. | |
| dc.language | English | |
| dc.subject.classification | thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general | en_US |
| dc.subject.classification | thema EDItEUR::P Mathematics and Science::PS Biology, life sciences | en_US |
| dc.subject.other | Agkistrodon | |
| dc.subject.other | leucine | |
| dc.subject.other | membrane | |
| dc.subject.other | phenylalanine | |
| dc.subject.other | venom peptides | |
| dc.subject.other | familial hyperaldosteronism type 3 | |
| dc.subject.other | KCNJ5 | |
| dc.subject.other | adrenal tumor | |
| dc.subject.other | β-catenin | |
| dc.subject.other | MALDI-IMS | |
| dc.subject.other | CYP11B2 | |
| dc.subject.other | PNU-74654 | |
| dc.subject.other | TNF receptor-1 | |
| dc.subject.other | apoptosis | |
| dc.subject.other | testicular cancer | |
| dc.subject.other | alveolar epithelial stem cells | |
| dc.subject.other | ACE2 | |
| dc.subject.other | SARS-CoV-2 | |
| dc.subject.other | COVID-19 | |
| dc.subject.other | RBD of spike glycoprotein | |
| dc.subject.other | metastatic microenvironment | |
| dc.subject.other | ovarian cancer | |
| dc.subject.other | exosomal microRNA | |
| dc.subject.other | biomarker | |
| dc.subject.other | early diagnosis | |
| dc.subject.other | BSG | |
| dc.subject.other | basigin | |
| dc.subject.other | CD147 | |
| dc.subject.other | MM | |
| dc.subject.other | multiple myeloma | |
| dc.subject.other | survival | |
| dc.subject.other | AP5M1 | |
| dc.subject.other | BAIAP2L1 | |
| dc.subject.other | CRISPR | |
| dc.subject.other | ENTPD2 | |
| dc.subject.other | master regulator | |
| dc.subject.other | LOC145474 | |
| dc.subject.other | MTOR | |
| dc.subject.other | PRRG1 | |
| dc.subject.other | VIM | |
| dc.subject.other | WFDC3 | |
| dc.subject.other | circulating tumor cells | |
| dc.subject.other | non-small-cell lung cancer | |
| dc.subject.other | single cell next generation sequencing | |
| dc.subject.other | nematode | |
| dc.subject.other | microenvironment | |
| dc.subject.other | cancer | |
| dc.subject.other | research | |
| dc.subject.other | ZEB2 | |
| dc.subject.other | prognosis | |
| dc.subject.other | immune cells | |
| dc.subject.other | cyclin D1 | |
| dc.subject.other | epidermal growth factor receptor (EGFR) | |
| dc.subject.other | stage I gastric cancer | |
| dc.subject.other | early gastric cancer | |
| dc.subject.other | node-negative gastric cancer | |
| dc.subject.other | B-cell maturation antigen (BCMA) | |
| dc.subject.other | soluble BCMA (sBCMA) | |
| dc.subject.other | multiple myeloma (MM) | |
| dc.subject.other | anti-BCMA CAR-T cell therapy | |
| dc.subject.other | INDEL | |
| dc.subject.other | genetic ancestry | |
| dc.subject.other | Amazon | |
| dc.subject.other | biomarkers | |
| dc.subject.other | KIRC | |
| dc.subject.other | GOT2 | |
| dc.subject.other | multi-omics | |
| dc.subject.other | epigenetics | |
| dc.subject.other | immune cell infiltration | |
| dc.subject.other | arsenic trioxide | |
| dc.subject.other | Parkin | |
| dc.subject.other | HeLa | |
| dc.subject.other | autophagy | |
| dc.subject.other | salivaomics | |
| dc.subject.other | breast cancer | |
| dc.subject.other | saliva | |
| dc.subject.other | molecular biological subtype | |
| dc.subject.other | HER2 status | |
| dc.subject.other | estrogen receptors | |
| dc.subject.other | progesterone receptors | |
| dc.subject.other | HPV DNA in breast | |
| dc.subject.other | nested PCR | |
| dc.subject.other | gastric cancer | |
| dc.subject.other | hsa-miR-942-3p | |
| dc.subject.other | AR | |
| dc.subject.other | MAPK/ERK signaling pathway | |
| dc.subject.other | HCC | |
| dc.subject.other | CTCs | |
| dc.subject.other | miRNAs | |
| dc.subject.other | proteomics | |
| dc.subject.other | fenbendazole | |
| dc.subject.other | microtubule polymerization | |
| dc.subject.other | self-administration | |
| dc.subject.other | EMT | |
| dc.subject.other | UQCRB | |
| dc.subject.other | ROS | |
| dc.subject.other | hypoxia | |
| dc.subject.other | HIF-1α | |
| dc.subject.other | deuterium-depleted water (DDW) | |
| dc.subject.other | deuterium-depleted yolk (DDyolk) | |
| dc.subject.other | anticancer drug development | |
| dc.subject.other | D/H ratio | |
| dc.subject.other | production of metabolic water | |
| dc.subject.other | ketogenic diet | |
| dc.subject.other | NEAT1 | |
| dc.subject.other | liver cancer cell line | |
| dc.subject.other | drug resistance | |
| dc.subject.other | SOD2 | |
| dc.subject.other | MAPK | |
| dc.subject.other | AKT | |
| dc.subject.other | rhabdomyosarcoma | |
| dc.subject.other | sarcoma | |
| dc.subject.other | mouse model | |
| dc.subject.other | Nf1 | |
| dc.subject.other | Ink4a/Arf | |
| dc.subject.other | vincristine | |
| dc.subject.other | n/a | |
| dc.title | Molecules at Play in Cancer | |
| dc.type | book | |
| oapen.identifier.doi | 10.3390/books978-3-0365-7302-1 | |
| oapen.relation.isPublishedBy | 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 | |
| oapen.relation.isbn | 9783036573038 | |
| oapen.relation.isbn | 9783036573021 | |
| oapen.pages | 366 | |
| oapen.place.publication | Basel |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||

